Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
04 Aug 2020
Historique:
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 15 8 2020
Statut: epublish

Résumé

Most currently approved strategies for the collection of saliva for COVID-19 diagnostics require specialized tubes containing buffers promoted for the stabilization of SARS-CoV-2 RNA and virus inactivation. Yet many of these are expensive, in limited supply, and not necessarily validated specifically for viral RNA. While saliva is a promising sample type as it can be reliably self-collected for the sensitive detection of SARS-CoV-2, the expense and availability of these collection tubes are prohibitive to mass testing efforts. Therefore, we investigated the stability of SARS-CoV-2 RNA and infectious virus detection from saliva without supplementation. We tested RNA stability over extended periods of time (2-25 days) and at temperatures representing at-home storage and elevated temperatures which might be experienced when cold chain transport may be unavailable. We found SARS-CoV-2 RNA in saliva from infected individuals is stable at 4°C, room temperature (~19°C), and 30°C for prolonged periods and found limited evidence for viral replication in saliva. This work demonstrates that expensive saliva collection options involving RNA stabilization and virus inactivation buffers are not always needed, permitting the use of cheaper collection options. Affordable testing methods are urgently needed to meet current testing demands and for continued surveillance in reopening strategies.

Identifiants

pubmed: 32793924
doi: 10.1101/2020.08.03.20165233
pmc: PMC7418742
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI128043
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

J Virol Methods. 2014 Mar;198:26-31
pubmed: 24384096
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Biomacromolecules. 2012 Jun 11;13(6):1724-32
pubmed: 22475261
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
PLoS One. 2014 Jul 11;9(7):e102045
pubmed: 25013895
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Nat Microbiol. 2020 Jul 10;:
pubmed: 32651556
Adv Dent Res. 2011 Apr;23(1):34-7
pubmed: 21441478
Clin Infect Dis. 2020 May 22;:
pubmed: 32442256

Auteurs

Isabel M Ott (IM)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Madison S Strine (MS)

Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA.

Anne E Watkins (AE)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Maikel Boot (M)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, 06510, USA.

Chaney C Kalinich (CC)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Christina A Harden (CA)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Chantal B F Vogels (CBF)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Arnau Casanovas-Massana (A)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Adam J Moore (AJ)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

M Catherine Muenker (MC)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Maura Nakahata (M)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Maria Tokuyama (M)

Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.

Allison Nelson (A)

Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

John Fournier (J)

Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

Santos Bermejo (S)

Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.

Melissa Campbell (M)

Department of Pediatrics, Division of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

Rupak Datta (R)

Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

Charles S Dela Cruz (CS)

Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.

Shelli F Farhadian (SF)

Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

Albert I Ko (AI)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.
Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.

Akiko Iwasaki (A)

Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.
Howard Hughes Medical Institute, New Haven, CT 06510, USA.

Nathan D Grubaugh (ND)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Craig B Wilen (CB)

Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA.

Anne L Wyllie (AL)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Classifications MeSH